Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

BSD Medical to begin Phase III pancreatic cancer study

BSD Medical, a manufacturer of services systems to treat cancer using heat therapy, will start Phase III pancreatic cancer study.

The randomized, multicenter study will use the BSD-2000 Hyperthermia System to deliver hyperthermia.

The study will compare hyperthermia with chemotherapy (gemcitabine plus cisplatin) to chemotherapy (gemcitabine) alone.

BSD said patients will be randomized following standard surgical resection of the tumor, and the enrollment is scheduled from 1 April 2012.